Manila, Philippines, Royal Philips (NYSE: PHG, AEX: PHIA) – St. Luke’s Medical Center Quezon City (SLMC)’s Catherization Lab has added an advancement in the diagnosis and treatment of stroke, brain aneurysms, brain and spinal AVMs and tumors, and other complex neurovascular conditions with the acquisition of Philips AlluraClarity. Philips’ AlluraClarity system with its powerful ClarityIQ technology provides high quality imaging for a comprehensive range of clinical procedures, achieving excellent visibility at low X-ray dose levels for patients of all sizes.
We are excited about the added advancement in the healthcare industry in the Philippines through AlluraClarity with Clarity IQ Technology that we recently installed at the St. Luke’s Medical Center Quezon City as it would help doctors to perform less invasive procedures that would facilitate the faster recovery of the patient. The Philips AlluraClarity incorporates powerful imaging technology to bring superb image quality at a fraction of the dose, further proving Philips’ commitment to improving patient’s health, well-being and quality of life
Ashwin Chari
Country Manager, Philips Philippines Inc.
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2018 sales of EUR 18.1 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
Senior Manager
Brand and Communications
Philips ASEAN Pacific